UBE2E3
Ubiquitin-conjugating enzyme E2 E3
Also known as: UB2E3_HUMAN, UbcH9
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q969T4
- Gene
- UBE2E3
- Ensembl
- ENSG00000170035
- Chromosome
- 2
- Canonical length
- 207 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
OverviewNCBI Gene
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. The encoded protein shares 100% sequence identity with the mouse and rat counterparts, which indicates that this enzyme is highly conserved in eukaryotes. Multiple alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jun 2013]
Canonical amino-acid sequenceUniProt
207 residues, UniProt reviewed canonical sequence.
>Q969T4|UBE2E3
1 MSSDRQRSDD ESPSTSSGSS DADQRDPAAP EPEEQEERKP SATQQKKNTK LSSKTTAKLS
61 TSAKRIQKEL AEITLDPPPN CSAGPKGDNI YEWRSTILGP PGSVYEGGVF FLDITFSSDY
121 PFKPPKVTFR TRIYHCNINS QGVICLDILK DNWSPALTIS KVLLSICSLL TDCNPADPLV
181 GSIATQYLTN RAEHDRIARQ WTKRYATLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UBE2E3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 164 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 164 nTPM
- tongue: 83 nTPM
- cerebral cortex: 81 nTPM
- hippocampal formation: 76 nTPM
- parathyroid gland: 75 nTPM
- thyroid gland: 69 nTPM
Single-cell type
- sertoli cells: 356 nCPM
- megakaryocytes: 278 nCPM
- platelets: 258 nCPM
- prostatic glandular cells: 255 nCPM
- differentiating spermatogonia: 249 nCPM
- oligodendrocyte progenitor cells: 244 nCPM
Immune cell
- plasmacytoid DC: 60 nTPM
- eosinophil: 54 nTPM
- non-classical monocyte: 37 nTPM
- basophil: 29 nTPM
- classical monocyte: 28 nTPM
- neutrophil: 26 nTPM
Brain region
- hippocampal formation: 98 nTPM
- cerebral cortex: 83 nTPM
- white matter: 76 nTPM
- spinal cord: 74 nTPM
- basal ganglia: 69 nTPM
- hypothalamus: 68 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.66
- gnomAD pLI
- 0.43
- gnomAD missense Z
- 2.75
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- protein K11-linked ubiquitination
- protein K48-linked ubiquitination
- protein K63-linked ubiquitination
- protein monoubiquitination
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of UBE2E3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UBE2E3 as an antibody target. Whether an autoantibody or antibody against UBE2E3 could matter depends on whether native UBE2E3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UBE2E3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UBE2E3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...